Cargando…

Design and pharmacodynamics of recombinant NZ2114 histidine mutants with improved activity against methicillin-resistant Staphylococcus aureus

NZ2114 is a promising candidate for therapeutic application owing to its potent activity to Staphylococcus aureus. Our objective was to identify NZ2114 derivatives with improved activity through substitution of His16 and His18 with residues Arginine and Lysine. Eight mutants were designed and expres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Huixian, Mao, Ruoyu, Teng, Da, Wang, Xiumin, Hao, Ya, Feng, Xingjun, Wang, Jianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321639/ https://www.ncbi.nlm.nih.gov/pubmed/28229435 http://dx.doi.org/10.1186/s13568-017-0345-x

Ejemplares similares

Increased intracellular activity of MP1102 and NZ2114 against Staphylococcus aureus in vitro and in vivo
por: Wang, Xiao, et al.
Publicado: (2018)

In vitro and in vivo antibacterial effect of NZ2114 against Streptococcus suis type 2 infection in mice peritonitis models
por: Jiao, Jian, et al.
Publicado: (2017)

Effect of NZ2114 against Streptococcus dysgalactiae biofilms and its application in murine mastitis model
por: Yang, Na, et al.
Publicado: (2022)

Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33
por: Mao, Ruoyu, et al.
Publicado: (2015)

Internalization, distribution, and activity of peptide H2 against the intracellular multidrug-resistant bovine mastitis-causing bacterium Staphylococcus aureus
por: Wang, Xiao, et al.
Publicado: (2019)

Antibacterial and immunomodulatory activities of insect defensins-DLP2 and DLP4 against multidrug-resistant Staphylococcus aureus
por: Li, Zhanzhan, et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of Fungal Defensin NZX Against Staphylococcus aureus-Induced Mouse Peritonitis Model
por: Zheng, Xueling, et al.
Publicado: (2022)

Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis
por: Yang, Na, et al.
Publicado: (2017)

Design and Pharmacodynamics of Recombinant Fungus Defensin NZL with Improved Activity against Staphylococcus hyicus In Vitro and In Vivo
por: Liu, He, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant Staphylococcus aureus
por: Rox, Katharina, et al.
Publicado: (2022)

An Enhanced Variant Designed From DLP4 Cationic Peptide Against Staphylococcus aureus CVCC 546
por: Li, Bing, et al.
Publicado: (2020)

2129. When Is Methicillin-resistant Staphylococcus aureus not Methicillin-resistant Staphylococcus aureus?
por: Gitman, Melissa R, et al.
Publicado: (2019)

Pharmacodynamic Functions of Synthetic Derivatives for Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) and Mycobacterium tuberculosis
por: Dinarvand, Mojdeh, et al.
Publicado: (2020)

Killing of Staphylococcus aureus and Salmonella enteritidis and neutralization of lipopolysaccharide by 17-residue bovine lactoferricins: improved activity of Trp/Ala-containing molecules
por: Hao, Ya, et al.
Publicado: (2017)

Therapeutic potential of a designed CSαβ peptide ID13 in Staphylococcus aureus-induced endometritis of mice
por: Li, Bing, et al.
Publicado: (2020)

Methicillin-Resistant Staphylococcus aureus
por: Tenover, Fred C., et al.
Publicado: (2004)

Methicillin-Resistant Staphylococcus Aureus
por: Al-Quorain, Abdulaziz
Publicado: (2016)

Recombinant Lysostaphin Protects Mice from Methicillin-Resistant Staphylococcus aureus Pneumonia
por: Chen, Chen, et al.
Publicado: (2014)

Methicillin-resistant Staphylococcus aureus in Taiwan
por: Chen, Feng-Jui, et al.
Publicado: (2005)

395 Impact of vancomycin pharmacokinetic/pharmacodynamic data on clinical outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children
por: Yoo, Reenar, et al.
Publicado: (2014)

Staphylococcus aureus and Methicillin-Resistant Staphylococcus aureus in Workers in the Food Industry
por: Strommenger, Birgit, et al.
Publicado: (2018)

Once-Daily Gentamicin Administration for Community-Associated Methicillin Resistant Staphylococcus aureus in an in vitro Pharmacodynamic Model: Preliminary Reports for the Advantages for Optimizing Pharmacodynamic Index
por: Kim, Sun Woo, et al.
Publicado: (2010)

Methicillin-Resistant Staphylococcus aureus in Poultry
por: Persoons, Davy, et al.
Publicado: (2009)

Bias in Methicillin Resistance of Staphylococcus aureus
por: Ataee, Ramezan Ali
Publicado: (2015)

Methicillin resistant Staphylococcus aureus meningitis
por: Pereira, Noella Maria Delia, et al.
Publicado: (2015)

Methicillin-resistant Staphylococcus aureus in Nepal
por: Shrestha, Lok Bahadur, et al.
Publicado: (2021)

The Pharmacodynamics Study of Insect Defensin DLP4 Against Toxigenic Staphylococcus hyicus ACCC 61734 in Vitro and Vivo
por: Ma, Xuanxuan, et al.
Publicado: (2021)

Identification of Methicillin-Resistant Staphylococcus Aureus From Methicillin-Sensitive Staphylococcus Aureus and Molecular Characterization in Quanzhou, China
por: Bai, Zhimin, et al.
Publicado: (2021)

Transesophageal Echocardiography vs. Transthoracic Echocardiography for Methicillin-Sensitive Staphylococcus aureus and Methicillin-Resistant Staphylococcus aureus Endocarditis
por: Henriquez, Elvis, et al.
Publicado: (2023)

Cysteine/Histidine-Dependent Amidohydrolase/Peptidase (CHAP)-Displayed Nano Phages: Antimicrobial Function against Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Rahimzadeh, Golnar, et al.
Publicado: (2020)

Pharmacodynamics of vancomycin in elderly patients aged 75 years or older with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia
por: Mizokami, Fumihiro, et al.
Publicado: (2013)

Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach
por: Garonzik, Samira M., et al.
Publicado: (2016)

Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children
por: Yoo, Reenar, et al.
Publicado: (2021)

Microbial Susceptibility and Plasmid Profiles of Methicillin-Resistant Staphylococcus aureus and Methicillin-Susceptible S. aureus
por: Shahkarami, Fatemeh, et al.
Publicado: (2014)

Resolution of Staphylococcus aureus (methicillin-resistant Staphylococcus aureus) osteomyelitis by oral linezolid
por: Gomes, PN, et al.
Publicado: (2003)

In vitro transfer of methicillin resistance determinants mecA from methicillin resistant Staphylococcus aureus (MRSA) to methicillin susceptible Staphylococcus aureus (MSSA)
por: Bitrus, Asinamai Athliamai, et al.
Publicado: (2017)

Resistance and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus
por: Liang, Jin, et al.
Publicado: (2023)

Phylogeographic variation in recombination rates within a global clone of methicillin-resistant Staphylococcus aureus
por: Castillo-Ramírez, Santiago, et al.
Publicado: (2012)

Rapid Acquisition of Linezolid Resistance in Methicillin-Resistant Staphylococcus aureus: Role of Hypermutation and Homologous Recombination
por: Iguchi, Shigekazu, et al.
Publicado: (2016)

Efficacy of Antimicrobial Peptide DP7, Designed by Machine-Learning Method, Against Methicillin-Resistant Staphylococcus aureus
por: Zhang, Rui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d286rqihfprn6l6pe969kk3a9q